mIDH1-mutated AML: ivosidenib in clinical practice

This Servier arranged webinar is for hematologists. The agenda for the webinar is: 12:00-12:05 – Introduction by Erik Holgén, Product Manager, Servier 12:05-12:30 – Prof. Dr. Michael Heuser - Will present the AGILE study and the clinical implications of the study results. 12:30-12:45 – Docent Vladimir Lazarevic - Focusing on treatment of mIDH1 AML patients […]

MNSCT 2024 Meeting

MNSCT 2024 Meeting  Date: 21 November 2024 Venue: Grand Hotel, Lund, Sweden or online Registration: https://mkon.nu/mnsct_2024/registration Program 12:00-12:55   Lunch, registration starts at 11.45 13:00-13:05   Welcome/Introduction  (Assoc. Prof. Andreas Björklund, Stockholm, Assoc. Prof. Jörg Cammenga, Lund) Session 1:             13:05-13:45   Prof. Dr. Thomas Schröder, University Hospital Essen, Essen Germany -- “Pharmacological preemptive and prophylactic approaches to prevent/treat relapse of   myeloid neoplasms after allo SCT” […]

AML Course Day 10 September 2025

The Educational Working Group is planning an "AML Course Day" in conjunction with the Nordic AML Meeting in Bergen 2025. The AML Course Day covers topics such as the current diagnostics and therapeutics, the latest with regard to MRD as well as clinically inclined discussions on emergencies and infectious problems in AML. The AML Course […]